Up a level |
Kovanda, Laura L, Walsh, Thomas J, Benjamin, Daniel K Jr, Arrieta, Antonio, Kaufman, David A, Smith, P Brian, Manzoni, Paolo, Desai, Amit V, Kaibara, Atsunori, Bonate, Peter L et al (show 1 more authors)
(2018)
Exposure-Response Analysis of Micafungin in Neonatal Candidiasis: Pooled Analysis of Two Clinical Trials.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 37 (6).
pp. 580-585.
Desai, Amit V, Kovanda, Laura L ORCID: 0000-0002-4493-4652, Hope, William W ORCID: 0000-0001-6187-878X, Andes, David, Mouton, Johan W, Kowalski, Donna L, Townsend, Robert W, Mujais, Salim and Bonate, Peter L
(2017)
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (12).
e01034-e01017.
Kovanda, Laura L ORCID: 0000-0002-4493-4652, Marty, Francisco M, Maertens, Johan, Desai, Amit V, Lademacher, Christopher, Engelhardt, Marc, Lu, Qiaoyang and Hope, William W ORCID: 0000-0001-6187-878X
(2017)
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (6).
e00101-e00117.
Kovanda, Laura L ORCID: 0000-0002-4493-4652, Desai, Amit V, Lu, Qiaoyang, Townsend, Robert W, Akhtar, Shahzad, Bonate, Peter and Hope, William W ORCID: 0000-0001-6187-878X
(2016)
Isavuconazole Population Pharmacokinetic Analysis Using Nonparametric Estimation in Patients with Invasive Fungal Disease (Results from the VITAL Study).
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 60 (8).
pp. 4568-4576.
Kovanda, Laura L ORCID: 0000-0002-4493-4652, Sullivan, Sean M, Smith, Larry R, Desai, Amit V, Bonate, Pete L and Hope, William W ORCID: 0000-0001-6187-878X
(2019)
Population Pharmacokinetic Modeling of VL-2397, A Novel Systemic Antifungal Agent: Analysis of a Single and Multiple Ascending Dose Study in Healthy Subjects.
Antimicrobial agents and chemotherapy, 63 (6).
e00163-e00119.
Kovanda, Laura L ORCID: 0000-0002-4493-4652, Desai, Amit V and Hope, William W ORCID: 0000-0001-6187-878X
(2017)
Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 44 (2).
pp. 143-151.